G&E Herbal Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	134.6	102.06	72.4	7.38	-19.88	-14.3	Upgrade
Depreciation & Amortization	10.48	10.38	9.33	9.4	9.33	9.21	Upgrade
Other Amortization	-	-	-	-	0	0	Upgrade
Loss (Gain) From Sale of Assets	0.01	0.01	0.01	0	0.02	0.01	Upgrade
Other Operating Activities	18.77	22.5	17.98	0.71	1.67	-2.51	Upgrade
Change in Accounts Receivable	-15.12	-3.04	-14.19	4.38	1.08	-2.22	Upgrade
Change in Inventory	-4.44	1.2	1.74	-5.69	-2.85	0.14	Upgrade
Change in Accounts Payable	-0.6	1.42	-2	2.47	-0.35	0.35	Upgrade
Change in Unearned Revenue	13.54	-10.01	23.39	71.39	0.28	0	Upgrade
Change in Other Net Operating Assets	11.4	10.16	4.82	9.92	1.52	10.09	Upgrade
Operating Cash Flow	168.66	134.68	113.48	99.96	-9.19	0.77	Upgrade
Operating Cash Flow Growth	26.67%	18.68%	13.52%	-	-	-	Upgrade
Capital Expenditures	-6.87	-5.92	-5.52	-2.95	-1.77	-5	Upgrade
Sale (Purchase) of Intangibles	-0.01	-0.08	-	-0.01	-0.22	-1.77	Upgrade
Investment in Securities	-95.61	-83.05	-82.04	5.4	9	15.9	Upgrade
Other Investing Activities	-0.02	-0.19	-0.87	0.07	-	-0.01	Upgrade
Investing Cash Flow	-102.51	-89.24	-88.43	2.51	7.01	9.13	Upgrade
Long-Term Debt Repaid	-	-0.77	-0.12	-	-	-	Upgrade
Net Debt Issued (Repaid)	-0.87	-0.77	-0.12	-	-	-	Upgrade
Common Dividends Paid	-31.76	-31.76	-	-	-	-	Upgrade
Financing Cash Flow	-32.63	-32.54	-0.12	-	-	-	Upgrade
Net Cash Flow	33.51	12.9	24.94	102.47	-2.18	9.9	Upgrade
Free Cash Flow	161.79	128.76	107.96	97.01	-10.96	-4.23	Upgrade
Free Cash Flow Growth	25.12%	19.26%	11.29%	-	-	-	Upgrade
Free Cash Flow Margin	54.98%	51.70%	59.50%	150.15%	-44.61%	-14.98%	Upgrade
Free Cash Flow Per Share	2.53	2.02	1.69	1.52	-0.17	-0.07	Upgrade
Cash Interest Paid	0.04	0.04	0	-	-	-	Upgrade
Cash Income Tax Paid	3.65	0.15	0.02	-	-	-	Upgrade
Levered Free Cash Flow	125.68	82.35	67.88	93.19	-5.52	-7.17	Upgrade
Unlevered Free Cash Flow	125.71	82.37	67.88	93.19	-5.52	-7.17	Upgrade
Change in Working Capital	4.79	-0.28	13.76	82.47	-0.32	8.36	Upgrade

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.